ONO PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4528 for the last quarter is 131.19 B JPY, and it's 5.41% lower compared to the previous quarter. The net income of Q3 23 is 36.05 B JPY.